These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1311 related items for PubMed ID: 16188283

  • 1. Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love").
    McNamara R, Kerans A, O'Neill B, Harkin A.
    Neuropharmacology; 2006 Jan; 50(1):69-80. PubMed ID: 16188283
    [Abstract] [Full Text] [Related]

  • 2. Association of caffeine to MDMA does not increase antinociception but potentiates adverse effects of this recreational drug.
    Camarasa J, Pubill D, Escubedo E.
    Brain Res; 2006 Sep 21; 1111(1):72-82. PubMed ID: 16889759
    [Abstract] [Full Text] [Related]

  • 3. MDMA ('Ecstasy') and methamphetamine combined: order of administration influences hyperthermic and long-term adverse effects in female rats.
    Clemens KJ, Cornish JL, Li KM, Hunt GE, McGregor IS.
    Neuropharmacology; 2005 Aug 21; 49(2):195-207. PubMed ID: 15993443
    [Abstract] [Full Text] [Related]

  • 4. Caffeine induces a profound and persistent tachycardia in response to MDMA ("Ecstasy") administration.
    McNamara R, Maginn M, Harkin A.
    Eur J Pharmacol; 2007 Jan 26; 555(2-3):194-8. PubMed ID: 17126829
    [Abstract] [Full Text] [Related]

  • 5. The effects of co-administration of 3,4-methylenedioxymethamphetamine ("ecstasy") or para-methoxyamphetamine and moclobemide at elevated ambient temperatures on striatal 5-HT, body temperature and behavior in rats.
    Stanley N, Salem A, Irvine RJ.
    Neuroscience; 2007 Apr 25; 146(1):321-9. PubMed ID: 17306465
    [Abstract] [Full Text] [Related]

  • 6. A study of the neurotoxic effect of MDMA ('ecstasy') on 5-HT neurones in the brains of mothers and neonates following administration of the drug during pregnancy.
    Colado MI, O'Shea E, Granados R, Misra A, Murray TK, Green AR.
    Br J Pharmacol; 1997 Jun 25; 121(4):827-33. PubMed ID: 9208155
    [Abstract] [Full Text] [Related]

  • 7. Effect of repeated ('binge') dosing of MDMA to rats housed at normal and high temperature on neurotoxic damage to cerebral 5-HT and dopamine neurones.
    Sanchez V, O'shea E, Saadat KS, Elliott JM, Colado MI, Green AR.
    J Psychopharmacol; 2004 Sep 25; 18(3):412-6. PubMed ID: 15358986
    [Abstract] [Full Text] [Related]

  • 8. Effects of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') and para-methoxyamphetamine on striatal 5-HT when co-administered with moclobemide.
    Freezer A, Salem A, Irvine RJ.
    Brain Res; 2005 Apr 11; 1041(1):48-55. PubMed ID: 15804499
    [Abstract] [Full Text] [Related]

  • 9. Increased effects of 3,4-methylenedioxymethamphetamine (ecstasy) in a rat model of depression.
    Jaehne EJ, Majumder I, Salem A, Irvine RJ.
    Addict Biol; 2011 Jan 11; 16(1):7-19. PubMed ID: 20192951
    [Abstract] [Full Text] [Related]

  • 10. 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites.
    Battaglia G, Yeh SY, O'Hearn E, Molliver ME, Kuhar MJ, De Souza EB.
    J Pharmacol Exp Ther; 1987 Sep 11; 242(3):911-6. PubMed ID: 2443644
    [Abstract] [Full Text] [Related]

  • 11. Gender differences in hyperthermia and regional 5-HT and 5-HIAA depletion in the brain following MDMA administration in rats.
    Wallinga AE, Grahlmann C, Granneman RA, Koolhaas JM, Buwalda B.
    Brain Res; 2011 Jun 29; 1398():13-20. PubMed ID: 21620380
    [Abstract] [Full Text] [Related]

  • 12. Risperidone attenuates and reverses hyperthermia induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats.
    Shioda K, Nisijima K, Yoshino T, Kuboshima K, Iwamura T, Yui K, Kato S.
    Neurotoxicology; 2008 Nov 29; 29(6):1030-6. PubMed ID: 18722468
    [Abstract] [Full Text] [Related]

  • 13. The relationship between hyperthermia and glycogenolysis in 3,4-methylenedioxymethamphetamine-induced serotonin depletion in rats.
    Darvesh AS, Gudelsky GA.
    Neurotoxicol Teratol; 2004 Nov 29; 26(4):571-7. PubMed ID: 15203179
    [Abstract] [Full Text] [Related]

  • 14. Behavioral and neurochemical effects of orally administered MDMA in the rodent and nonhuman primate.
    Slikker W, Holson RR, Ali SF, Kolta MG, Paule MG, Scallet AC, McMillan DE, Bailey JR, Hong JS, Scalzo FM.
    Neurotoxicology; 1989 Nov 29; 10(3):529-42. PubMed ID: 2576304
    [Abstract] [Full Text] [Related]

  • 15. 3,4-Methylenedioxymethamphetamine ("ecstasy") selectively destroys brain serotonin terminals in rhesus monkeys.
    Insel TR, Battaglia G, Johannessen JN, Marra S, De Souza EB.
    J Pharmacol Exp Ther; 1989 Jun 29; 249(3):713-20. PubMed ID: 2471824
    [Abstract] [Full Text] [Related]

  • 16. 3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein.
    Wang X, Baumann MH, Xu H, Rothman RB.
    Synapse; 2004 Sep 15; 53(4):240-8. PubMed ID: 15266556
    [Abstract] [Full Text] [Related]

  • 17. Serotonin mediates rapid changes of striatal glucose and lactate metabolism after systemic 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") administration in awake rats.
    Gramsbergen JB, Cumming P.
    Neurochem Int; 2007 Jul 15; 51(1):8-15. PubMed ID: 17475367
    [Abstract] [Full Text] [Related]

  • 18. Sprague-Dawley rats display metabolism-mediated sex differences in the acute toxicity of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy).
    Fonsart J, Menet MC, Declèves X, Galons H, Crété D, Debray M, Scherrmann JM, Noble F.
    Toxicol Appl Pharmacol; 2008 Jul 01; 230(1):117-25. PubMed ID: 18358511
    [Abstract] [Full Text] [Related]

  • 19. The hyperthermic and neurotoxic effects of 'Ecstasy' (MDMA) and 3,4 methylenedioxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metabolizer phenotype.
    Colado MI, Williams JL, Green AR.
    Br J Pharmacol; 1995 Aug 01; 115(7):1281-9. PubMed ID: 7582557
    [Abstract] [Full Text] [Related]

  • 20. Potentiation of 3,4-methylenedioxymethamphetamine-induced 5-HT release in the rat substantia nigra by clorgyline, a monoamine oxidase A inhibitor.
    Hewton R, Salem A, Irvine RJ.
    Clin Exp Pharmacol Physiol; 2007 Oct 01; 34(10):1051-7. PubMed ID: 17714093
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 66.